AAAAAA
Results: 1-25/76
Authors:
Martarello, L
Kilts, CD
Ely, T
Owens, MJ
Nemeroff, CB
Camp, M
Goodman, MM
Citation: L. Martarello et al., Synthesis and characterization of fluorinated and iodinated pyrrolopyrimidines as PET/SPECT ligands for the CRF1 receptor, NUCL MED BI, 28(2), 2001, pp. 187-195
Authors:
Stout, SC
Owens, MJ
Lindsey, KP
Knight, DL
Nemeroff, CB
Citation: Sc. Stout et al., Effects of sodium valproate on corticotropin-releasing factor systems in rat brain, NEUROPSYCH, 24(6), 2001, pp. 624-631
Authors:
O'Brien, D
Skelton, KH
Owens, MJJ
Nemeroff, CB
Citation: D. O'Brien et al., Are CRF receptor antagonists potential antidepressants?, HUM PSYCHOP, 16(1), 2001, pp. 81-87
Authors:
Stout, SC
Owens, MJ
Nemeroff, CB
Citation: Sc. Stout et al., Neurokinin(1) receptor antagonists as potential antidepressants, ANN R PHARM, 41, 2001, pp. 877-906
Authors:
DeVane, CL
Nemeroff, CB
Citation: Cl. Devane et Cb. Nemeroff, Clinical pharmacokinetics of quetiapine - An atypical antipsychotic, CLIN PHARMA, 40(7), 2001, pp. 509-522
Authors:
DeVane, CL
Nemeroff, CB
Citation: Cl. Devane et Cb. Nemeroff, An evaluation of risperidone drug interactions, J CL PSYCH, 21(4), 2001, pp. 408-416
Authors:
Binder, EB
Kinkead, B
Owens, MJ
Kilts, CD
Nemeroff, CB
Citation: Eb. Binder et al., Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: Evidence from animal models of sensorimotor gating, J NEUROSC, 21(2), 2001, pp. 601-608
Authors:
Miller, AH
Musselman, DL
Nemeroff, CB
Citation: Ah. Miller et al., Paroxetine for the prevention of depression induced by interferon alfa - Reply, N ENG J MED, 345(5), 2001, pp. 376-376
Authors:
Musselman, DL
Lawson, DH
Gumnick, JF
Manatunga, AK
Penna, S
Goodkin, RS
Greiner, K
Nemeroff, CB
Miller, AH
Citation: Dl. Musselman et al., Paroxetine for the prevention of depression induced by high-dose interferon alfa, N ENG J MED, 344(13), 2001, pp. 961-966
Authors:
Percy, AK
Nemeroff, CB
Citation: Ak. Percy et Cb. Nemeroff, Chromosome 22q and the mind-brain interface - Bedside to bench to bedside, NEUROLOGY, 57(3), 2001, pp. 377-378
Authors:
Nemeroff, CB
Citation: Cb. Nemeroff, Advances in the pathophysiology and treatment of psychiatric disorders: Implications for internal medicine - Preface, MED CLIN NA, 85(3), 2001, pp. XV-XVI
Authors:
Sharma, RP
Martis, B
Rosen, C
Jonalagadda, J
Nemeroff, CB
Bissette, G
Citation: Rp. Sharma et al., CSF thyrotropin-releasing hormone concentrations differ in patients with schizoaffective disorder from patients with schizophrenia or mood disorders, J PSYCH RES, 35(5), 2001, pp. 287-291
Authors:
Radke, JM
Owens, MJ
Nemeroff, CB
Citation: Jm. Radke et al., The effects of glutamate receptor agonists on neurotensin release using invivo microdialysis, EUR J PHARM, 411(1-2), 2001, pp. 129-134
Authors:
Owens, MJ
Knight, DL
Nemeroff, CB
Citation: Mj. Owens et al., Second-generation SSRIs: Human monoamine transporter binding profile of escitalopram and R-fluoxetine, BIOL PSYCHI, 50(5), 2001, pp. 345-350
Authors:
Coplan, JD
Smith, ELP
Altemus, M
Scharf, BA
Owens, MJ
Nemeroff, CB
Gorman, JM
Rosenblum, LA
Citation: Jd. Coplan et al., Variable foraging demand rearing: Sustained elevations in cisternal cerebrospinal fluid corticotropin-releasing factor concentrations in adult primates, BIOL PSYCHI, 50(3), 2001, pp. 200-204
Authors:
Heim, C
Nemeroff, CB
Citation: C. Heim et Cb. Nemeroff, The role of childhood trauma in the neurobiology of mood and anxiety disorders: Preclinical and clinical studies, BIOL PSYCHI, 49(12), 2001, pp. 1023-1039
Authors:
Musselman, DL
Miller, AH
Porter, MR
Manatunga, A
Gao, F
Penna, S
Pearce, BD
Landry, J
Glover, S
McDaniel, JS
Nemeroff, CB
Citation: Dl. Musselman et al., Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings, AM J PSYCHI, 158(8), 2001, pp. 1252-1257
Authors:
Nemeroff, CB
Evans, DL
Gyulai, L
Sachs, GS
Bowden, CL
Gergel, IP
Oakes, R
Pitts, CD
Citation: Cb. Nemeroff et al., Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression, AM J PSYCHI, 158(6), 2001, pp. 906-912
Authors:
Heim, C
Newport, DJ
Bonsall, R
Miller, AH
Nemeroff, CB
Citation: C. Heim et al., Altered pituitary-adrenal axis responses to provocative challenge tests inadult survivors of childhood abuse, AM J PSYCHI, 158(4), 2001, pp. 575-581
Authors:
Nemeroff, CB
Citation: Cb. Nemeroff, Progress in the battle with the black dog: Advances in the treatment of depression, AM J PSYCHI, 158(10), 2001, pp. 1555-1557
Authors:
Stowe, ZN
Cohen, LS
Ritchie, JC
Owens, MJ
Nemeroff, CB
Citation: Zn. Stowe et al., Paroxetine in breast milk - Dr. Stowe and colleagues reply, AM J PSYCHI, 158(1), 2001, pp. 144-145
Authors:
Skelton, KH
Nemeroff, CB
Owens, MJ
Citation: Kh. Skelton et al., A comparison of plasma alprazolam concentrations following different routes of chronic administration in the Sprague-Dawley rat: implications for psychotropic drug research, PSYCHOPHAR, 151(1), 2000, pp. 72-76
Authors:
Bouwer, C
Claassen, J
Dinan, TG
Nemeroff, CB
Citation: C. Bouwer et al., Prednisone augmentation in treatment-resistant depression with fatigue andhypocortisolaemia: A case series, DEPRESS ANX, 12(1), 2000, pp. 44-50
Authors:
Nemeroff, CB
Citation: Cb. Nemeroff, More than one-half of a decade of experience with venlafaxine dual serotonin-norepinephrine reuptake inhibitor, DEPRESS ANX, 12, 2000, pp. 1-1
Authors:
Ressler, KJ
Nemeroff, CB
Citation: Kj. Ressler et Cb. Nemeroff, Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders, DEPRESS ANX, 12, 2000, pp. 2-19